Navigation Links
Navigating Cancer Announces Milestones Related to Patient Education Program

SEATTLE, Jan. 7, 2014 /PRNewswire/ -- Navigating Cancer, the leading provider of oncology specific patient portals, announces milestones related to their Patient Education and Medication Adherence Program launched in early 2013. Navigating Cancer's Patient Education Program allows cancer programs to digitize their education and establish intuitive rules to automatically deliver information to individual patients based on their diagnosis and medications, without requiring additional work from staff members.  Additionally, the program allows material to be delivered at specific points during the patient's treatment journey — after diagnosis to aid understanding, or during treatment milestones to help patients learn how to take their medications and manage side effects to improve adherence and compliance.  In 2014, HITECH Meaningful Use Stage 2 requires practices to use certified EHR technology to provide personalized patient education, a change from Stage 1 where the patient education measure was optional. Navigating Cancer also supports the Infobutton standard for patient education as required for Stage 2.

Navigating Cancer's Patient Education Program achieved the following in 2013:

  • 97% of providers met HITECH Meaningful Use Stage 1 requirement for patient education
  • 97% of patients at participating practices signed a HIPAA authorization to opt in to the program, indicating a high preference for receiving personalized education from their providers
  • Nearly 300 different educational programs were implemented to educate specific cancer patients with content from the National Cancer Institute, pharmaceutical manufacturers and other cancer specific partners. 74% of registered patients received education specific to their diagnosis and/or medications.

"Our goals for everything we do are two-fold: to empower cancer patients and make it easier for cancer programs to provide quality cancer care. We're pleased that this program accomplishes both," said Gena Cook, CEO of Navigating Cancer.  "Patients receive the right information at the right time from their care provider, which helps them participate and take an active role in their care and recovery."

"This program has really improved our educational efforts for our patients and it's been less work for our staff.  The fact that pharmaceutical companies are participating has helped us meet federal incentives and created a great experience for our patients," said Kim Woofter, CEO, Michiana Hematology Oncology.

About Navigating Cancer

Navigating Cancer's mission is to empower cancer survivors and healthcare professionals to improve the quality and efficiency of care. Navigating Cancer's Patient Engagement Portal provides cancer programs with a branded, online extension of their care model to engage their patients while meeting patient centered care requirements. The company was founded in 2008 by technology and healthcare veterans and is based in Seattle, Washington.

SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Reveals New Strategies for Navigating Big Data in the Pharmaceutical Industry
2. New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information
3. Tennessee Oncology Chooses Navigating Cancers Patient Engagement Portal
4. Health Outcomes Liaisons Key to Pharmaceutical Sector Navigating Payer-Focused Marketplace
5. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
6. Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma
7. Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients
8. Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nations Deadliest Cancers
9. According to Surveyed U.S. Oncologists, Perjeta is Prescribed to Over One-Third of First-Line Advanced/Metastatic HER2-Positive, HR-Negative Breast Cancer Patients
10. Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
11. New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints
Post Your Comments:
(Date:11/30/2015)... 2015 Booth #4303 – The Imaging Components business ... a broader array of products in a new booth (#4303) ... North America in Chicago ... feature X-ray components "At the Heart of Imaging." Products will ... from Varian,s Claymount brand, and computer-aided diagnostic software from MeVis ...
(Date:11/30/2015)... NAMUR , Belgium , Nov. 30, ... life sciences company focused on developing blood-based diagnostic tests for ... announced the Company will present at the LD Micro Conference, ... Los Angeles, CA. Attending from VolitionRx will ... and Scott Powell , Vice President of Investor Relations. ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... According to an article published November 13th by People ... to show her Instagram followers that the praise that they were bestowing on her ... she didn’t “want to mislead any mommy's who just had babies and are stressing,” ...
(Date:11/30/2015)... ... ... Cycling, running, and walking are regular Sunday activities for many South Floridians, ... 2016. , That’s when the 7th annual ANF Group Tour de Broward will ... families at Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored by ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one ... , Their study showed that small molecule analogs that target the functions of ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar ... and adults, according to a new study by researchers at the School of Public ... and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public ...
(Date:11/30/2015)... Pittsburgh, PA (PRWEB) , ... November 30, 2015 ... ... according to a new study by UPMC and KingMed Diagnostics ... UPMC over three years found that consultation with UPMC pathologists resulted in significantly ...
Breaking Medicine News(10 mins):